 |
 |
 |
Journal articles
T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition
Abstract : Tumor immunotherapy has had demonstrable efficacy in patients with cancer. The most promising results have been with T-cell-based therapies. These include adoptive cell transfer of tumor-infiltrating lymphocytes, genetically engineered T cells, and immune checkpoint inhibitor antibodies. In this review, we describe the different T-cell-based strategies currently in clinical trials and put their applications, present and future, into perspective. Cancer Immunol Res; 3(10); 1115-22. ©2015 AACR
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01216199
Contributor : Laurent Jonchère <>
Submitted on : Thursday, October 15, 2015 - 5:06:35 PM
Last modification on : Thursday, January 14, 2021 - 11:15:44 AM
Contributor : Laurent Jonchère <>
Submitted on : Thursday, October 15, 2015 - 5:06:35 PM
Last modification on : Thursday, January 14, 2021 - 11:15:44 AM
Links full text
